- Progyny press release ( NASDAQ: PGNY ): Q4 GAAP EPS of $0.03 beats by $0.02 .
- Revenue of $214.3M (+68.0% Y/Y) beats by $2.52M .
- FY23 Outlook: Revenue is projected to be $1,000 million to $1,030 million, reflecting growth of 27% to 31%, vs. $1.02B consensus.
- Net income is projected to be $27.0 million to $32.7 million, or $0.26 to $0.32 per diluted share, on the basis of approximately 103 million assumed weighted-average fully diluted-shares outstanding
- FQ1 outlook: Revenue is projected to be $245.0 million to $250.0 million, reflecting growth of 42% to 45%, vs. $230.80M consensus.
- Net income is projected to be $6.8 million to $8.6 million, or $0.07 to $0.08 per diluted share, on the basis of approximately 102 million assumed weighted-average fully diluted-shares outstanding
For further details see:
Progyny GAAP EPS of $0.03 beats by $0.02, revenue of $214.3M beats by $2.52M, FQ1 guidance above consensus